Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01001614

CERILLIANT™ Morphine-6-beta-D-glucuronide Solution, 100 μg/mL in Methanol:Water (1:1), Sold by MilliporeSigma™ Supelco™

Catalog No. 01001614 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-614 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-614 Supplier MilliporeSigma Supelco Supplier No. M0961ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Certified reference material

Morphine-6-β-D-glucuronide is a primary plasma and urinary metabolite of the opiate analgesic morphine. Sold under trade names including MS Contin™, Kadian™, Oramorph™, and Roxanol for pain relief, morphine is also a commonly abused recreational drug. This certified analytical reference standard is suitable for a variety of GC/MS or LC/MS applications from pain prescription monitoring and urine drug testing to clinical toxicology and forensic analysis.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 20290-09-9
Linear Formula C23H27NO9
MDL Number MFCD00079434
UN Number UN 1993C 3 / PGIII
Concentration 100 μg/mL in methanol:water (1:1)
Formula Weight 461.46
Packaging Ampule
Quantity 1 mL
Flash Point 24°C (75.2°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.